Print Page  |  Close Window

SEC
10-Q
BIOTELEMETRY, INC. filed this Form 10-Q on 10/31/2018
Entire Document
 << Previous Page | Next Page >>
BIOTELEMETRY, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
(Unaudited)


 
Three Months Ended September 30, 2018
(in thousands)
Healthcare
 
Research
 
Other
 
Total Consolidated
Payor/Service Line
 
 
 
 
 
 
 
Remote cardiac monitoring services - Medicare
$
34,638

 
$

 
$

 
$
34,638

Remote cardiac monitoring services - commercial payors
49,558

 

 

 
49,558

Clinical trial support and related services

 
13,464

 

 
13,464

Technology devices, consumable and related services

 

 
2,353

 
2,353

Total
$
84,196

 
$
13,464

 
$
2,353

 
$
100,013

 
Nine Months Ended September 30, 2018
(in thousands)
Healthcare
 
Research
 
Other
 
Total Consolidated
Payor/Service Line
 
 
 
 
 
 
 
Remote cardiac monitoring services - Medicare
$
101,452

 
$

 
$

 
$
101,452

Remote cardiac monitoring services - commercial payors
150,018

 

 

 
150,018

Clinical trial support and related services

 
37,254

 

 
37,254

Technology devices, consumable and related services

 

 
7,145

 
7,145

Total
$
251,470

 
$
37,254

 
$
7,145

 
$
295,869

Remote Cardiac Monitoring Services Revenue (Healthcare segment)
Healthcare segment revenue is generated by remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. We offer cardiologists, electrophysiologists, neurologists and primary care physicians a full spectrum of solutions, which provides them with a single source of cardiac monitoring services. We bill after service commences.
Performance obligations are determined based on the nature of the services provided by us. With our remote cardiac monitoring services, the patient receives the benefits from the cardiac monitoring service over time, resulting in a time elapsed output method for revenue recognition. We believe that this method provides an accurate depiction of the transfer of value over the term of the performance obligation because the level of effort in providing these services is consistent during the service period.
A summary of the payment arrangements with payors is as follows:
Medicare and Contracted Payors: We determine the transaction price based on negotiated prices for services provided, on a case-rate basis, as provided for under the relevant Current Procedural Terminology (“CPT”) codes.
Non-Contracted Payors: Non-contracted commercial and government insurance carriers often reimburse out of network rates provided for under the relevant CPT codes on a case rate basis. Our transaction price includes implicit price concessions based on our historical collection experience for our non-contracted patients
We are utilizing the portfolio approach practical expedient in ASC 606 for our patient contracts in the Healthcare segment. We account for the contracts within each portfolio as a collective group, rather than individual contracts. Based on our history with these portfolios and the similar nature and

17

 << Previous Page | Next Page >>